|
Market Closed -
Nasdaq
06:30:00 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 18.45 USD | -0.67% |
|
-1.60% | +94.42% |
| 14/08 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 13/08 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Fortress Biotech, Inc.(FBIO)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
- Consensus Fortress Biotech, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
